Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-05-22 Sale |
2024-05-24 4:12 pm |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
4,350 | $2.6402 | $11,485 | 101,404 (Direct) |
View |
2023-10-11 Sale |
2023-10-12 4:00 pm |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
785 | $2.02 | $1,586 | 100,069 (Direct) |
View |
2023-09-11 Sale |
2023-09-13 4:06 pm |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
711 | $2.2 | $1,564 | 100,854 (Direct) |
View |
2023-08-11 Sale |
2023-08-14 4:00 pm |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
682 | $2.36 | $1,610 | 101,565 (Direct) |
View |
2023-07-11 Sale |
2023-07-12 4:29 pm |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
687 | $2.34 | $1,608 | 102,247 (Direct) |
View |
2023-06-12 Sale |
2023-06-14 4:28 pm |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
610 | $2.64 | $1,610 | 102,934 (Direct) |
View |
2023-05-11 Sale |
2023-05-15 4:00 pm |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
562 | $2.89 | $1,624 | 103,544 (Direct) |
View |
2023-04-11 Sale |
2023-04-12 5:02 pm |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
840 | $1.839 | $1,545 | 104,106 (Direct) |
View |
2023-03-13 Sale |
2023-03-15 4:00 pm |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
892 | $1.7532 | $1,564 | 104,946 (Direct) |
View |
2023-02-13 Sale |
2023-02-15 4:01 pm |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
8,474 | $2.45 | $20,761 | 105,838 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-05-31 Option Award |
2025-06-03 4:00 pm |
2025-05-31 2034-02-14 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
72,000 | $0 | 110,400 (Direct) |
View |
2025-03-10 Option Award |
2025-03-12 4:00 pm |
2025-03-10 2034-02-14 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
38,400 | $0 | 38,400 (Direct) |
View |
2025-02-18 Option Award |
2025-02-20 4:00 pm |
N/A 2035-02-17 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
225,500 | $0 | 225,500 (Direct) |
View |
2025-01-07 Exercise |
2025-01-10 4:14 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
6,000 | $0 | 153,910 (Direct) |
View |
2025-01-07 Exercise |
2025-01-10 4:14 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
6,000 | $0.511 | 153,910 (Direct) |
View |
2024-05-22 Exercise |
2024-05-24 4:12 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
16,043 | $0 | 101,404 (Direct) |
View |
2024-05-22 Exercise |
2024-05-24 4:12 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
16,043 | $0.511 | 101,404 (Direct) |
View |
2024-02-15 Option Award |
2024-02-16 4:42 pm |
N/A 2034-02-14 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
175,000 | $0 | 175,000 (Direct) |
View |
2023-10-11 Exercise |
2023-10-12 4:00 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,292 | $0 | 100,069 (Direct) |
View |
2023-10-11 Exercise |
2023-10-12 4:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,292 | $0.511 | 100,069 (Direct) |
View |
2023-09-11 Exercise |
2023-09-13 4:06 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,291 | $0 | 100,854 (Direct) |
View |
2023-09-11 Exercise |
2023-09-13 4:06 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,291 | $0.511 | 100,854 (Direct) |
View |
2023-08-11 Exercise |
2023-08-14 4:00 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,292 | $0 | 101,565 (Direct) |
View |
2023-08-11 Exercise |
2023-08-14 4:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,292 | $0.511 | 101,565 (Direct) |
View |
2023-07-11 Exercise |
2023-07-12 4:29 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,292 | $0 | 102,247 (Direct) |
View |
2023-07-11 Exercise |
2023-07-12 4:29 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,292 | $0.511 | 102,247 (Direct) |
View |
2023-06-12 Exercise |
2023-06-14 4:28 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,291 | $0 | 102,934 (Direct) |
View |
2023-06-12 Exercise |
2023-06-14 4:28 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,291 | $0.511 | 102,934 (Direct) |
View |
2023-05-11 Exercise |
2023-05-15 4:00 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,291 | $0 | 103,544 (Direct) |
View |
2023-05-11 Exercise |
2023-05-15 4:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,291 | $0.511 | 103,544 (Direct) |
View |
2023-04-11 Exercise |
2023-04-12 5:02 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,292 | $0 | 104,106 (Direct) |
View |
2023-04-11 Exercise |
2023-04-12 5:02 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,292 | $0.511 | 104,106 (Direct) |
View |
2023-03-13 Exercise |
2023-03-15 4:00 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,291 | $0 | 104,946 (Direct) |
View |
2023-03-13 Exercise |
2023-03-15 4:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,291 | $0.511 | 104,946 (Direct) |
View |
2023-02-16 Option Award |
2023-02-16 5:18 pm |
N/A 2033-02-15 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
187,500 | $0 | 187,500 (Direct) |
View |
2023-02-13 Exercise |
2023-02-15 4:01 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
27,500 | $0 | 105,838 (Direct) |
View |
2023-02-13 Exercise |
2023-02-15 4:01 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
27,500 | $0.511 | 105,838 (Direct) |
View |
2022-02-11 Option Award |
2022-02-15 4:00 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
110,000 | $0 | 110,000 (Direct) |
View |
2021-08-09 Option Award |
2021-08-09 5:34 pm |
N/A 2031-08-08 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |